NCT05727033

Brief Summary

Project FEDE-ITS will improve the STI knowledge and its treatment, of adolescents in the 1st and 2nd year of compulsory secondary education in the intervention group compared to compared to the control group, and will modify the sexual risk practices and the perception of risky practices of alcohol and other drug use during sex of participants in the intervention group compared to the control group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 14, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

February 14, 2023

Status Verified

November 1, 2022

Enrollment Period

6 months

First QC Date

November 23, 2022

Last Update Submit

February 3, 2023

Conditions

Keywords

Adolescentssexually transmitted infectionsprimary health caresexual healthhealth education

Outcome Measures

Primary Outcomes (12)

  • Knowledge of the five most prevalent STIs

    Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points. \- "List the Sexually Transmitted Infections (STIs) you know, Tick one: * HIV * Candida albicans * Gonorrhoea * Chlamydia * Escherichia coli * Treponema / Syphilis * COVID-19 * Human Papilloma (HPV)"

    pre-intervention at the baseline day

  • Knowledge of the five most prevalent STIs

    Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points. \- "List the Sexually Transmitted Infections (STIs) you know, Tick one: * HIV * Candida albicans * Gonorrhoea * Chlamydia * Escherichia coli * Treponema / Syphilis * COVID-19 * Human Papilloma (HPV)"

    end-of-intervention at the same day

  • Knowledge of the five most prevalent STIs

    Discrete quantitative variable. It will be assessed by scoring. 5 scoring items: correct answer 1 point and incorrect answer 0 points. The maximum score will be 5 points (HIV: 1 point, Chlamydia: 1 point, Syphilis or Treponema pallidum: 1 point, Gonorrhoea or Neisseria gonorrhoeae: 1 point, HPV or Papilloma Virus: 1 point), and the minimum 0 points. \- "List the Sexually Transmitted Infections (STIs) you know, Tick one: * HIV * Candida albicans * Gonorrhoea * Chlamydia * Escherichia coli * Treponema / Syphilis * COVID-19 * Human Papilloma (HPV)"

    post-intervention assessments six months after the intervention

  • Knowledge of different barrier methods.

    Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score) \- "How many barrier methods do you know? (tick the options you consider \* correct): Select all the options that apply. * Male condom * Post-coital pill * Aspirin * Abstinence * Female condom"

    pre-intervention at the baseline day

  • Knowledge of different barrier methods.

    Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score) \- "How many barrier methods do you know? (tick the options you consider \* correct): Select all the options that apply. * Male condom * Post-coital pill * Aspirin * Abstinence * Female condom"

    end-of-intervention at the same day

  • Knowledge of different barrier methods.

    Discrete quantitative variable. It will be collected in the questionnaire using a question with multiple correct options. There will be 5 options and 2 correct. Scoring: From 0 (minimum score) to 5 points (maximum score) \- "How many barrier methods do you know? (tick the options you consider \* correct): Select all the options that apply. * Male condom * Post-coital pill * Aspirin * Abstinence * Female condom"

    post-intervention assessments six months after the intervention

  • Use of barrier methods in sexual intercourse.

    Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. * Always * Almost Always * Sometimes * Never

    pre-intervention at the baseline day

  • Use of barrier methods in sexual intercourse.

    Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. * Always * Almost Always * Sometimes * Never

    end-of-intervention at the same day

  • Use of barrier methods in sexual intercourse.

    Ordinal qualitative variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- In the case of having sex, have you used barrier methods (condom or female condom) from the very start (including oral sex), OR If you do not have sex, do you think that when you do have sex you will always use barrier methods (condom-female condom), including oral sex? Tick one. * Always * Almost Always * Sometimes * Never

    post-intervention assessments six months after the intervention

  • Drug use during sexual intercourse.

    Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use \* alcohol or other drugs when you have sex? Tick one. * Always * Almost Always * Sometimes * Never

    pre-intervention at the baseline day

  • Drug use during sexual intercourse.

    Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use \* alcohol or other drugs when you have sex? Tick one. * Always * Almost Always * Sometimes * Never

    end-of-intervention at the same day

  • Drug use during sexual intercourse.

    Qualitative ordinal variable. It will be recorded in the questionnaire using a Likert scale (always, almost always, sometimes, never) \- "If you have sex, do you use alcohol or other drugs when you have sex? OR If you do not have sex, do you think that when you do you will use \* alcohol or other drugs when you have sex? Tick one. * Always * Almost Always * Sometimes * Never

    post-intervention assessments six months after the intervention

Secondary Outcomes (3)

  • Role in sexual intercourse.

    pre-intervention at the baseline day

  • Role in sexual intercourse.

    end-of-intervention at the same day

  • Role in sexual intercourse.

    post-intervention assessments six months after the intervention

Study Arms (2)

Intervention Group

ACTIVE COMPARATOR

The intervention of training-participatory activity will last between 45 and 60 minutes, divided into theoretical training of 15-30 minutes followed by discussion training of 30 minutes. Based on the projection of the posters, photographs and the short film, the pupils will be asked to participate and work on the problem of STIs as well as possible solutions. The group techniques of photo-talk and presentation with a discussion using the short film will be used. Finally, the training includes Kahoot®, a tool for learning and reviewing concepts in a fun, quiz-like way. Four multiple-choice questions have been included. They will learn in a participatory way about STIs, risk practices, barrier methods and health resources to consult or go to in case of suspicion of contracting an STI. For the activity, a sequence of drawings and signs has been designed to put STIs, their causes and how to prevent infection into context.

Behavioral: Participatory teaching group

Control Group

SHAM COMPARATOR

Following the indications of the Department of Education and the "Health and School" Programme, non specific training intervention will be carried out in the control group out during the study period.

Behavioral: Sham control group

Interventions

The intervention will be called FEDE-ITS® methodology. This methodology is self-designed and self-developed and draws on previous work in equivalent populations. It is based on teaching in a participatory way knowledge and healthy attitudes related to the five most prevalent STIs in the province of Barcelona and Lleida, the methods to avoid contagion, and the health resources that can be consulted in case of infection, contact with an infected person or concerns. In addition, a gender perspective is incorporated to contribute to freer and more egalitarian relationships and reduce the likelihood of violence against women which develops in adolescence. The cross-cutting themes of the training are: health, pleasure, self-esteem, knowledge-based freedom of choice, equality between people and respect for sexual freedom. Therefore, the ultimate goal is to prevent abusive power relations and macho violence.

Also known as: Extraordinarily Fun Training in compulsory secondary Education - Sexually Transmitted Infections methodology, FEDE-ITS® methodology
Intervention Group

The "Health and School" program was implemented to promote health in schools, and for this reason the program's nurse attends annually to address problems related to sexual affective health within the curricular itinerary of each school, but not specifically on sexually transmitted infections or gender perspective.

Also known as: Sham intervention group, Health and school program (Department of Health. Government of Catalonia)
Control Group

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • pupils in the 1st and 2nd years of compulsory secondary education in the municipalities of Sant Andreu de la Barca, Balaguer, Alcarràs and Barcelona
  • prior authorisation of the school administration,
  • prior authorisation of the pupil
  • prior authorisation of the parents/legal guardians by submitting the information sheet and collecting the informed consent.

You may not qualify if:

  • pupils refusing to participate
  • families refusing to participate
  • school administration refusing to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

CAP Sant Andreu de la Barca

Sant Andreu de la Barca, Barcelona, 08740, Spain

Location

CAP Alcarràs

Alcarràs, Lleida, 25180, Spain

Location

CAP Balaguer

Balaguer, Lleida, 25600, Spain

Location

CAP Gótic

Barcelona, 08002, Spain

Location

MeSH Terms

Conditions

Chlamydia InfectionsGonorrheaAcquired Immunodeficiency SyndromeSexually Transmitted DiseasesHealth Education

Interventions

Health

Condition Hierarchy (Ancestors)

Chlamydiaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSexually Transmitted Diseases, BacterialCommunicable DiseasesGenital DiseasesUrogenital DiseasesNeisseriaceae InfectionsHIV InfectionsBlood-Borne InfectionsSexually Transmitted Diseases, ViralLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsAdherence InterventionsMedication AdherencePatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Population Characteristics

Study Officials

  • David Pedrazas-López, PhD, MD

    Institut Català de la Salut

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Pedrazas-López, PhD, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The person in charge of analyzing the data collected in the study will not know if the participants belong to the intervention group or the control group, which will be identified with an alphanumeric code.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Cluster randomised clinical trial with the control group, unblinded and with pre-intervention, end-of-intervention and post-intervention assessments six months after the intervention. A 1:1 allocation ratio is established.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2022

First Posted

February 14, 2023

Study Start

March 1, 2023

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

February 14, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations